UCB Ventures


UCB Ventures is an evergreen strategic corporate venture fund established in 2017, focused on creating value from novel insights and technologies to transform the lives of patients with severe diseases. The firm invests in early-stage companies in the US and Europe, particularly those developing novel therapeutic modalities and platforms that address novel biology. UCB Ventures is committed to long-term investments and works closely with entrepreneurs to maximize the potential of its portfolio companies.

UCB Ventures

UCB Ventures

87 Cambridgepark Drive, 02140 Cambridge, MA, USA


Portfolio

Developing conditionally activated siRNA technology for central nervous system diseases.

#Biotechnology

Developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases.

#Biotechnology

Exploiting protein splicing to develop the next generation of gene therapies.

#Biotechnology

Developing an in vivo engineering platform to produce cancer-fighting cells inside the patient’s body.

#Biotechnology

Focused on the development of breakthrough treatments for neurological disorders.

#Biotechnology

Focused on transforming the treatment of kidney disease.

#Biotechnology


Key People

Head of UCB Ventures

UCB Ventures Partner

UCB Ventures Principal

LinkedIn

Venture Associate

UCB Ventures Analyst

Team Coordinator

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.